OncoCyte Corporation (OCX) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 3 Buy, 2 Hold.
The consensus price target is $8.00, representing an upside of 150% from the current price $3.20.
OCX Stock — 12-Month Price Forecast
$8.00
▲ +150.00% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for OncoCyte Corporation, the price target is $8.00.
The average price target represents a +150.00% change from the last price of $3.20.
OCX Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to OncoCyte Corporation in the past 3 months
